Clinical Trial Update: Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intravenous AMD3100 (plerixafor) for mobilization and matched related transplantation in advanced hematologic malignancies has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hematologic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-08-24